Life Science & Biotech

Health care VC hits new Indiana low in 2011

February 6, 2012
J.K. Wall
Indiana companies landed just $14.1 million in venture funding last year, the lowest amount of capital flowing to  the state’s health care sector since BioEnterprises began tracking such deals in 2005.
More

Dow Agro posts record fourth quarter profit

February 2, 2012
 IBJ Staff and Associated Press
The Indianapolis-based unit of Dow Chemical Co. saw earnings grow to $142 million, a fourth-quarter record and double the $72 million reported for the 2010 period.
More

Lilly's quarterly profit tumbles, but tops Wall Street estimates

January 31, 2012
J.K. Wall
Patent expirations on Gemzar and Zyprexa contributed to the 27-percent earnings decline, but CEO John Lechleiter touted better-than-expected sales of other products.
More

Purdue hopes center simplifies commercialization

January 30, 2012
J.K. Wall
Purdue University's new Innovation and Commercialization Center is supposed to be a one-stop shop for professors to get help developing their research into products and for outside investors to find out what research is taking place there.
More

Eli Lilly unit plans to buy feed-enzyme maker

January 24, 2012
Associated Press
Drugmaker Eli Lilly and Co.'s Elanco animal health division plans to buy a privately held maker of feed-enzyme products that improve poultry, egg and meat production.
More

Indianapolis-area mergers and acquisitions in 2011Restricted Content

January 21, 2012
A number of acquisitions last year disclosed no sale price. In the Indianapolis area, those deals ranged from MacAllister Machinery's purchase of a Caterpillar dealership in Michigan to Herff Jones' acquisition of a Memphis, Tenn.-headquartered maker of cheerleading uniforms.
More

City set to cancel tax abatement for medical device firm

January 18, 2012
Polymer Technology Systems said in 2007 that it would make a $3 million investment at its operation on Zionsville Road and create 110 jobs.
More

At long last, Roche wins approval of Nano

January 16, 2012
J.K. Wall
The OK for a new blood glucose monitor comes more than two years after FDA officials declined to approve a previous version of the Nano, which in rare cases generated inflated blood sugar readings because it did not distinguish properly between the sugars glucose and maltose.
More

Indiana's medical device workforce will need skills upgradeRestricted Content

January 14, 2012
J.K. Wall
A new report by BioCrossroads says 53 percent of the 20,000 jobs in Indiana’s medical-device sector require no more than a high school education.
More

National life sciences law firm opens office hereRestricted Content

January 7, 2012
 IBJ Staff
New York-based Epstein Becker Green already has clients here, including Biomet and Roche Diagnostics.
More

Endocyte stays course despite being battered by investorsRestricted Content

December 31, 2011
J.K. Wall
After spending most of 2011 as a Wall Street darling, the year ended ugly for Endocyte Inc. But CEO Ron Ellis thinks the West Lafayette-based drug developer is in better position than ever.
More

Filing: Roche considered leaving Indy

December 27, 2011
J.K. Wall
It’s hard to believe now, but as recently as two years ago, Indianapolis was close to losing its 15th-largest employer. Roche Diagnostics Corp. was looking seriously at moving its 2,900-employee North American headquarters out of Indianapolis.
More

Ex-Dow Agro scientist receives seven years for economic espionage

December 21, 2011
Kexue Huang was sentenced after pleading guilty in October to sending Dow AgroSciences trade secrets to China and Germany.
More

Ex-Dow Agro scientist set to be sentenced in espionage case

December 21, 2011
Scott Olson
Federal prosecutors are recommending that Kexue Huang be sentenced to 87 months in prison for sending trade secrets worth millions to China and Germany.
More

SEC accuses Positron CEO of misleading investors

November 28, 2011
Chris O'Malley
Regulators allege CEO Patrick G. Rooney diverted millions of dollars from a hedge fund into the struggling Fishers company without investors' knowledge.
More

Purdue courts Silicon Valley partnershipsRestricted Content

November 26, 2011
Chris O'Malley
The office, at NASA Ames Research Center, in Mountain View, Calif., aims to commercialize Purdue-developed technology through partnerships with private industry.
More

JONES: Patent reform is mixed bag for life sciences companiesRestricted Content

November 26, 2011
Kristin Jones / Special to IBJ
For Indiana's life sciences sector, the change both raises hopes and creates challenges for continued growth.
More

Cancer-drug firm Endocyte to build commercial team in IndianapolisRestricted Content

November 12, 2011
J.K. Wall
Endocyte employs 12 people in Indianapolis and plans to add three or four more commercial executives there over the next year and a half as it anticipates approval of its ovarian cancer medication in Europe.
More

Drug shortages hit Lilly, Endocyte

November 7, 2011
J.K. Wall
The nation’s shortage of certain drugs is threatening to affect research trials being conducted by Eli Lilly and Co. and Endocyte Inc.
More

Ortho firms pull back on doc payments

October 31, 2011
J.K. Wall
The number of payments in excess of $1 million didn’t change substantially from year to year, but orthopedic companies sharply cut their fees to surgeons who received the smallest amounts.
More

Insurer Humana's quarterly profit climbs 13 percent

October 31, 2011
Associated Press
Humana Inc. raised its 2011 earnings forecast, following the lead set by other big insurers, including competitor WellPoint Inc.
More

Drug theft is ongoing battle for pharmaciesRestricted Content

October 29, 2011
Chris O'Malley
Over the last 12 months, the Indiana Board of Pharmacy has conducted license litigation involving at least 35 pharmacy personnel statewide who've been accused of stealing drugs from work.
More

Indiana software firm growing with life sciences focusRestricted Content

October 29, 2011
Katie Maurer
RND Group fills development gaps for companies.
More

Dow Agro improves quarterly revenue, profit

October 27, 2011
 IBJ Staff and Bloomberg News
Indianapolis-based Dow AgroSciences on Thursday reported record third-quarter sales of $1.2 billion, up 27 percent from the same period a year ago.
More

BioCrossroads seeds upstart medical device maker

October 20, 2011
Chris O'Malley
BioCrossroads’ Indiana Seed Fund has invested $300,000 in a startup company chaired by a former Eli Lilly and Co. executive developing an absorbable stent.
More
Page  << 1 2 3 4 5 6 7 8 9 10 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. OK Larry, let's sign Lance, shore up the PG and let's get to the finals.

  2. A couple of issues need some clarification especially since my name was on the list. I am not sure how this information was obtained and from where. For me, the amount was incorrect to begin with and the money does not come to me personally. I am guessing that the names listed are the Principal Investigators (individual responsible for the conduct of the trail) for the different pharmaceutical trials and not the entity which receives the checks. In my case, I participate in Phase II and Phase III trials which are required for new drug development. Your article should differentiate the amount of money received for consulting, for speaking fees, and for conduct of a clinical trial for new drug development. The lumping of all of these categories may give the reader a false impression of physicians just trying to get rich. The Sunshine Law may help to differentiate these categories in the future. The public should be aware that the Clinical Trial Industry could be a real economic driver for Indiana since these revenues supports jobs and new job creation. Nationally, this account for 10-20 billion which our State is missing out on to a large degree. Yes, new drug and technology development has gotten most of the attention (e.g. CTSI, BioCrossroads, etc.) However, serious money is being left on the table by not participating in the clinical trials to get those new drugs and medical devices on the market!!!! I guess that this is not sexy enough for academia.

  3. The address given for the Goldfish Swim Club is the Ace Hardware, is it closing?

  4. Out of state management and ownership. If Kite controlled it, everything would be leased. Of course, due to the roundabout, there is limited access to the south side of 116th now also. Just have to go down to the light.

  5. Hey smudge, You're opposed to arresting people for minor crimes? Sounds great! We should only focus on murders and such, right? Let's stand around and wait until someone shoots someone before we act. Whatever we do, we should never question anyone, frisk anyone, or arrest anyone unless they are actively engaged in shooting or stabbing. Very sound!

ADVERTISEMENT